About
Lynetta Wang is a biochemistry student at Imperial College London and Venture Intern at age1, a $35M early-stage longevity-focused venture firm. She is also a healthcare sector analyst at Queen's Tower Capital and an Emergent Ventures grant recipient (Cohort 44, August 2025). Notably young — she was a 6th-year secondary school student in Ireland in 2023–2024 (winning the Eli Lilly award at BTYSTE 2024) before transitioning into the London longevity ecosystem.
Areas of interest
longevitybiotechdrug discoveryaging biologyAI-driven therapeuticstranslation scienceclimate techcarbon removalventure capitallife sciences